Genetic predisposition in children cancers in 2011;Les prédispositions génétiques aux cancers de l'enfant en 2011

Bulletin du Cancer

Volumn 98, Issue 5, 2011, Pages 459-475

  Gauthier Villars, Marion ^a   Stoppa Lyonnet, Dominique ^a  

^a INSTITUT CURIE   (France)

Author keywords

Cancer predisposition syndrome; Childhood; Predisposition gene test

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; CHILDHOOD CANCER; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; MALFORMATION SYNDROME; REVIEW;

EID: 79958732248     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1355     Document Type: Review

References (23)

1. Lacour B. Incidence des cancers de l'enfant - Incidence globale. In : Sommelet D, Clavel J, Lacour B, editors. Épidémiologie des cancers de l'enfant. France : Springer, 2009, p. 31-47.
2. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991 ; 63 : 993-9.
3. Merks JHM, Caron HN, Hennekam RCM. High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet 2005 ; 134A : 132-43. (Pubitemid 40446208)
4. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004 ; 10 : 789-99. (Pubitemid 39070849)
5. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci 1971 ; 68 : 820-3.
6. Comings DE. A general theory of carcinogenesis. Proc Natl Acad Sci 1973 ; 70 : 3324-8.
7. Friend SH, Bernards R, Rogelj R, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986 ; 323 : 643-6. (Pubitemid 16008560)
8. Shojaei-Brosseau T, Chompret A, Abel A, et al. Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France. Pediatr Blood Cancer 2004 ; 42 : 99-105. (Pubitemid 38173463)
9. Mossé YP, Laudenslager M, Longo L, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008 ; 455 : 930-5.
10. Janoueix-Lerosey I, Lequin D, Brugières L, et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008 ; 455 : 967-70.
11. Chen Y, Takita J, Choi YL, et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 2008 ; 455 : 971-4.
12. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001 ; 29 : 465-8. (Pubitemid 34326699)
13. Denayer E, de Ravel T, Legius E. Clinical and molecular aspects of RAS related disorders. J Med Genet 2008 ; 45 : 695-703.
14. Gripp KW. Tumor predisposition in Costello syndrome. Am J Med Genet C Semin Med Genet 2005 ; 137 : 72-7. (Pubitemid 41113664)
15. Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009 ; 325 : 965.
16. Chompret A, Brugières L, Ronsin M, et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 2000 ; 82 : 1932-7. (Pubitemid 30326453)
17. Frebourg T, Abel A, Bonaiti-Pellie C, et al. Li-Fraumeni syndrome: update, new data and guidelines for clinical management. Bull Cancer 2001 ; 88 : 581-7. (Pubitemid 32678350)
18. Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991 ; 64 : 959-61.
19. Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002 ; 31 : 306-10.
20. Garré ML, Cama A, Bagnosco F, et al. Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome - A new clinical perspective. Clin Cancer Res 2009 ; 15 : 2463-71.
21. Brugières L, Pierron G, Chompret A, et al. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J Med Genet 2010 ; 47 : 142-4.
22. Lindor NM, McMaster ML, Lindor CJ, Greene MH. Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr 2008 ; 38 : 1-93.
23. Taniguchi E, Cho MJ, Arenkiel BR, et al. Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer 2009 ; 53 : 136-44.